Phyllodes tumours of the breast: a consensus review

被引:304
作者
Tan, Benjamin Y. [1 ]
Acs, Geza [2 ]
Apple, Sophia K. [3 ]
Badve, Sunil [4 ,5 ]
Bleiweiss, Ira J. [6 ]
Brogi, Edi [7 ]
Calvo, Jose P. [8 ]
Dabbs, David J. [9 ]
Ellis, Ian O. [10 ]
Eusebi, Vincenzo [11 ]
Farshid, Gelareh [12 ,13 ]
Fox, Stephen B. [14 ]
Ichihara, Shu [15 ]
Lakhani, Sunil R. [16 ]
Rakha, Emad A. [10 ]
Reis-Filho, Jorge S. [7 ]
Richardson, Andrea L. [17 ,18 ]
Sahin, Aysegul [19 ]
Schmitt, Fernando C. [20 ]
Schnitt, Stuart J. [18 ,21 ]
Siziopikou, Kalliopi P. [22 ]
Soares, Fernando A. [23 ]
Tse, Gary M. [24 ]
Vincent-Salomon, Anne [25 ]
Puay Hoon Tan [1 ]
机构
[1] Singapore Gen Hosp, Dept Pathol, Singapore 169856, Singapore
[2] Womens Pathol Consultants, Ruffolo Hooper & Associates, Tampa, FL USA
[3] Univ Calif Los Angeles, Dept Pathol, Med Ctr, Santa Monica, CA USA
[4] Indiana Univ, Dept Pathol, Clarian Pathol Lab, Indianapolis, IN 46204 USA
[5] Indiana Univ, Clarian Pathol Lab, Dept Internal Med, Indianapolis, IN 46204 USA
[6] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA
[7] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[8] Hosp Univ Ramon & Cajal, Serv Anat Patol, Madrid, Spain
[9] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[10] Univ Nottingham, Dept Histopathol, Nottingham City Hosp NHS Trust, Nottingham NG7 2RD, England
[11] M Malpighi Univ Bologna, Sez Anat & Istol Patol, Bologna, Italy
[12] Univ Adelaide, BreastScreen SA, Discipline Med, Adelaide, SA, Australia
[13] SA Pathol, Directorate Surg Pathol, Adelaide, SA, Australia
[14] Peter MacCallum Canc Ctr, Dept Pathol, East Melbourne, Vic, Australia
[15] Nagoya Med Ctr, Dept Pathol, Nagoya, Aichi, Japan
[16] Univ Queensland, Sch Med & Pathol Queensland, Royal Brisbane & Womens Hosp, Clin Res Ctr, Brisbane, Qld, Australia
[17] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[18] Harvard Univ, Sch Med, Boston, MA USA
[19] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Div Pathol, Lab Med, Houston, TX 77030 USA
[20] Lab Natl Sante, Luxembourg, Luxembourg
[21] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[22] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA
[23] AC Camargo Canc Ctr, Dept Anat Pathol, Sao Paulo, Brazil
[24] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China
[25] Inst Curie, Pole Pathol Genet Immunol, Paris, France
基金
美国国家卫生研究院;
关键词
classification; fibroadenoma; malignant; metastasis; phyllodes; CORE NEEDLE-BIOPSY; SPINDLE-CELL CARCINOMA; EPITHELIAL-STROMAL INTERACTIONS; FREQUENT MED12 MUTATIONS; CYSTOSARCOMA-PHYLLODES; LOCAL RECURRENCE; FIBROEPITHELIAL TUMORS; HISTOLOGIC FEATURES; SURGICAL-TREATMENT; FEMALE BREAST;
D O I
10.1111/his.12876
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Phyllodes tumours constitute an uncommon but complex group of mammary fibroepithelial lesions. Accurate and reproducible grading of these tumours has long been challenging, owing to the need to assess multiple stratified histological parameters, which may be weighted differently by individual pathologists. Distinction of benign phyllodes tumours from cellular fibroadenomas is fraught with difficulty, due to overlapping microscopic features. Similarly, separation of the malignant phyllodes tumour from spindle cell metaplastic carcinoma and primary breast sarcoma can be problematic. Phyllodes tumours are treated by surgical excision. However, there is no consensus on the definition of an appropriate surgical margin to ensure completeness of excision and reduction of recurrence risk. Interpretive subjectivity, overlapping histological diagnostic criteria, suboptimal correlation between histological classification and clinical behaviour and the lack of robust molecular predictors of outcome make further investigation of the pathogenesis of these fascinating tumours a matter of active research. This review consolidates the current understanding of their pathobiology and clinical behaviour, and includes proposals for a rational approach to the classification and management of phyllodes tumours.
引用
收藏
页码:5 / 21
页数:17
相关论文
共 135 条
[1]  
Abdalla Hassan M, 2006, J Egypt Natl Canc Inst, V18, P125
[2]   Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors [J].
Abe, Makoto ;
Miyata, Satoshi ;
Nishimura, Seiichiro ;
Iijima, Kotaro ;
Makita, Masujiro ;
Akiyama, Futoshi ;
Iwase, Takuji .
BREAST CANCER, 2011, 18 (04) :268-272
[3]  
Aiyer H M, 2000, Indian J Pathol Microbiol, V43, P5
[4]   Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression [J].
Ang, Mei Kim ;
Ooi, Aik Seng ;
Thike, Aye Aye ;
Tan, Patrick ;
Zhang, Zhongfa ;
Dykema, Karl ;
Furge, Kyle ;
Teh, Bin Tean ;
Tan, Puay Hoon .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (02) :319-329
[5]  
[Anonymous], BREAST J
[6]  
[Anonymous], NAT GENET
[7]  
[Anonymous], MOD PATHOL S2
[8]  
[Anonymous], PROBLEMS BREAST PATH
[9]   Cystosarcoma phyllodes: mastectomy, lumpectomy, or lumpectomy plus irradiation [J].
August, DA ;
Kearney, T .
SURGICAL ONCOLOGY-OXFORD, 2000, 9 (02) :49-52
[10]   Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors [J].
Barth, RJ .
BREAST CANCER RESEARCH AND TREATMENT, 1999, 57 (03) :291-295